1. Yuti P, Wutti-in Y, Sawasdee N, Kongkla K, Phanthaphol N, Choomee K, Chieochansin T, Panya A, Junking M, Yenchitsomanus P, Sujjitjoon J. . Anti-CD19 chimeric antigen receptor T cells secreting anti-PD-L1 single-chain variable fragment attenuate PD-L1 mediated T cell inhibition . Int. Immunopharmacol. 2022;113():109442.

2. Wathikthinnakon M, Luangwattananun P, Sawasdee N, Chiawpanit C, Lee VS, Nimmanpipug P, Tragoolpua Y, Rotarayanont S, Sangsuwannukul T, Phanthaphol N, Wutti‑in Y, Somboonpatarakun C, Chieochansin T, Junking M, Sujjitjoon J, Yenchitsomanus P, Panya A . Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells . Sci. Rep. 2022;12(1):6154.

3. Wutti-in Y, Sujjitjoon J, Sawasdee N, Panya A, Kongkla K, Yuti P, Yongpitakwattana P, Thepmalee C, Junking M, Chieochansin T, Poungvarin N, Yamabhai M, Yenchitsomanus P. . Development of a novel anti-CD19 CAR containing a fully human scFv and three costimulatory domains . Front Oncol 2022;11(802876):.

4. Luangwattananun, P. Junking, M. Sujjitjoon, J. Wutti-In, Y. Poungvarin, N. Thuwajit, C. Yenchitsomanus, P. T.. Fourth-generation chimeric antigen receptor T cells targeting folate receptor alpha antigen expressed on breast cancer cells for adoptive T cell therapy. Breast Cancer Res Treat 2021;186(1):25-36.

5. Wutti-in Y, Vongchan P, Thananchai H. . Polyfunctionality of natural killer cell in healthy donor . WJST 2016;13():217-280.

6. Sriwichai, C. Jiraudommongkol, M. Wutti-In, Y. Vongchan, P.. Production of an anticanine globulin (polyspecific) reagent for laboratory investigation. J Small Anim Pract . 2011;52(9):476-483.

7. Vongchan P, Wutti-in Y, Sajomsang W, Gonil P, Kothan S, Linhardt RJ. . N,N,N- Trimethyl chitosan nanoparticles for the delivery of monoclonal antibodies against hepatocellular carcinoma cells . Carbohydr. Polym. 2011;85(1):215-220.

8. Vongchan, P. Kothan, S. Wutti-In, Y. Linhardt, R. J.. Inhibition of human tumor xenograft growth in nude mice by a novel monoclonal anti-HSPG isolated from human liver. Anticancer Res. 2011;31(12):4067-74.